Latest Insider Transactions at Incyte Corp (INCY)
This section provides a real-time view of insider transactions for Incyte Corp (INCY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INCYTE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INCYTE CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 14
2023
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,246
+12.86%
|
-
|
|
Jul 14
2023
|
Thomas Tray Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,015
+19.69%
|
-
|
|
Jul 03
2023
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,044
-10.61%
|
$374,728
$62.08 P/Share
|
|
Jul 03
2023
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
6,215
-14.39%
|
$385,330
$62.08 P/Share
|
|
Jul 03
2023
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,442
-7.41%
|
$523,404
$62.08 P/Share
|
|
Jul 03
2023
|
Maria E Pasquale EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
8,468
-12.36%
|
$525,016
$62.08 P/Share
|
|
Jul 03
2023
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,073
-7.91%
|
$376,526
$62.08 P/Share
|
|
Jul 03
2023
|
Thomas Tray Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,136
-5.78%
|
$70,432
$62.08 P/Share
|
|
Jul 03
2023
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
5,783
-6.83%
|
$358,546
$62.08 P/Share
|
|
Jul 03
2023
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
6,304
-8.08%
|
$390,848
$62.08 P/Share
|
|
Jul 03
2023
|
Herve Hoppenot Chairman / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
43,467
-9.99%
|
$2,694,954
$62.08 P/Share
|
|
Jun 30
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,024
+0.01%
|
-
|
|
Jun 30
2023
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
380
+2.54%
|
$23,560
$62.25 P/Share
|
|
Jun 30
2023
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+3.18%
|
$24,180
$62.25 P/Share
|
|
Jun 14
2023
|
Jean Jacques Bienaime Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,505
+13.92%
|
-
|
|
Jun 14
2023
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,505
+14.99%
|
-
|
|
Jun 14
2023
|
Susanne Schaffert Director |
SELL
Payment of exercise price or tax liability
|
Direct |
488
-11.82%
|
$29,768
$61.44 P/Share
|
|
Jun 14
2023
|
Susanne Schaffert Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,505
+37.75%
|
-
|
|
Jun 14
2023
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,505
+15.2%
|
-
|
|
Jun 14
2023
|
Otis W Brawley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,505
+29.79%
|
-
|
|
Jun 14
2023
|
Katherine A High Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,505
+23.86%
|
-
|
|
Jun 14
2023
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,505
+17.89%
|
-
|
|
Jun 14
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
5,010
+0.05%
|
-
|
|
Jun 05
2023
|
Pablo J Cagnoni President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
179,613
+50.0%
|
-
|
|
Mar 31
2023
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
318
+2.64%
|
$22,896
$72.27 P/Share
|
|
Mar 31
2023
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
326
+3.5%
|
$23,472
$72.27 P/Share
|
|
Mar 31
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
858
+0.01%
|
-
|
|
Mar 13
2023
|
Baker Bros. Advisors LP |
BUY
Exercise of conversion of derivative security
|
Indirect |
40,000
+0.36%
|
$880,000
$22.74 P/Share
|
|
Feb 16
2023
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,693
+6.09%
|
$240,045
$65.42 P/Share
|
|
Feb 13
2023
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,179
-0.76%
|
$94,320
$80.08 P/Share
|
|
Jan 31
2023
|
Maria E Pasquale EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
802
-1.16%
|
$67,368
$84.06 P/Share
|
|
Jan 31
2023
|
Maria E Pasquale EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
802
+1.14%
|
$59,348
$74.78 P/Share
|
|
Jan 30
2023
|
Maria E Pasquale EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
60,024
-12.56%
|
$5,042,016
$84.77 P/Share
|
|
Jan 30
2023
|
Maria E Pasquale EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
60,024
+11.04%
|
$4,441,776
$74.19 P/Share
|
|
Jan 26
2023
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,419
-4.34%
|
$205,615
$85.0 P/Share
|
|
Jan 26
2023
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Open market or private sale
|
Direct |
7,000
-14.05%
|
$595,000
$85.0 P/Share
|
|
Jan 26
2023
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+12.32%
|
$476,000
$68.62 P/Share
|
|
Jan 20
2023
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+8.21%
|
-
|
|
Jan 20
2023
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
6,159
+14.49%
|
-
|
|
Jan 20
2023
|
Michael James Morrissey EVP, Head of Tech. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
6,159
+9.12%
|
-
|
|
Jan 20
2023
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+5.55%
|
-
|
|
Jan 20
2023
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,196
+6.29%
|
-
|
|
Jan 20
2023
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+6.03%
|
-
|
|
Jan 20
2023
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+6.78%
|
-
|
|
Jan 20
2023
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+6.03%
|
-
|
|
Jan 20
2023
|
Thomas Tray Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,833
+12.72%
|
-
|
|
Jan 20
2023
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+4.19%
|
-
|
|
Jan 20
2023
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+10.42%
|
-
|
|
Jan 19
2023
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
105
-0.19%
|
$8,715
$83.88 P/Share
|
|
Jan 19
2023
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
105
-0.35%
|
$8,715
$83.88 P/Share
|